This trial is evaluating whether Breast-dedicated PET camera will improve 1 primary outcome in patients with Breast Cancer. Measurement will happen over the course of 1 day.
This trial requires 20 total participants across 1 different treatment group
This trial involves a single treatment. Breast-dedicated PET Camera is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase < 1 and are in the first stage of evaluation with people.
"Breast cancer treatments are evolving with every year advances. The main treatments on breast cancer are: Surgery (open or Minimally Invasive), Radiation, Chemotherapy, and Targeted Therapy. But since radiation can be harmful, most people prefer minimally invasive surgical methods. Moreover, it is important that people choose treatment for them in a well-informed manner. For some drugs, there is a debate if the benefits exceed the risks. Some drugs have side-effects such as the risk of premature death, cardiovascular disease, and strokes. In other cases, the benefits seem so big that some doctors prefer to do it." - Anonymous Online Contributor
"The signs, symptoms and risks for breast cancer vary significantly depending on women's age, genetics, their own attitudes and the way they perceive risks and chances. There are common symptoms experienced by all women but each woman may have a different experience. The same breast cancer risks seen in the UK may have more or less different risks elsewhere. There are a variety of signs that can help guide women through the diagnostic process of being evaluated. The mammographic images taken during the diagnostic process can help us to understand and work with the signs and symptoms." - Anonymous Online Contributor
"Most common [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) signs are painful breasts that are lumpy and may show bleeding, an unpleasant taste in the mouth or a change in nipple discharge or size. These symptoms may be present before any breast lump is noticed.\n" - Anonymous Online Contributor
"Approximately 1,095,300 in the United States will be diagnosed with breast cancer in 2025. Approximately 76,600 will die from breast cancer. The median life expectancy after breast cancer diagnosis is 89 months. Nearly half of women will have no breast cancer symptoms at the time of diagnosis. In many women, breast cancer is diagnosed after a long time with no known symptoms, delaying any treatment. Women should have mammograms every 3 years after menopause. People with a family history of breast cancer should have their mothers and sisters screened as early as 45 years of age. People with a family history of breast cancer should also consider themselves in high-risk groups." - Anonymous Online Contributor
"The causes of breast cancer are only partially known. Obesity, smoking, family history, and physical exam are all factors associated with breast cancer and are major contributors to breast cancer. Breast cancers in women who are underweight tend to have a poorer prognosis than those who are overweight. The role played by diet in promoting or preventing breast cancer remains uncertain." - Anonymous Online Contributor
"Only a small percentage of women with breast cancer can be cured. However, with good treatment, many women with breast cancer can do well and live with minimal symptoms, and women with local recurrent disease can do well after multiple cycles of systemic therapy." - Anonymous Online Contributor
"The therapeutic application of pet cameras is extremely promising in the imaging of cancer. Moreover, it can help in the treatment of the cancer by a non-invasive way such as with X-ray or ultrasound imaging." - Anonymous Online Contributor
"There are some very new therapies being used to treat [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer): One of them was shown to increase breast cancer survival, and another might provide a target for new cancer drugs (“druggable”). Another that boosts some other parts of the immune system seems to work in clinical trials and may lead to new drug treatments for other cancers. Researchers may find a drug that can help people with cancer overcome their fear of hospitals and doctors. Researchers may discover chemicals that can stop breast cancer cells from growing and spreading. Scientists may discover new drugs that can help people with cancer cope and get through difficult situations. New drugs might even help people live longer and healthier lives." - Anonymous Online Contributor
"Overall, women ages 40 and younger (mean age = 42.9 years) are most likely to get breast cancer, while those ages over 55 (mean = 64.4 years) are equally likely to get breast cancer. Men (mean = 66.5) and women under 20 (mean = 39.9) are less likely to get breast cancer. The average age at diagnosis is 55.5 years. The average age a woman is diagnosed with breast cancer is 58.8 years. A woman will be diagnosed with breast cancer sometime after the age of 45 but usually no later than the age of 65 or after. \n- List of U.S." - Anonymous Online Contributor
"Primary benign tumors of the breast are more common in postmenopausal women and appear to regress, often without medical intervention, after menopause. This group also has a reduced risk of developing [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) later in life. A substantial number of premenopausal women have breast cancer and, in many cases, the disease appears during or after menopause. Primary benign cancers are the leading cause of breast cancer in women younger than 50 and may have to play a significant role in breast cancer etiology in other age groups." - Anonymous Online Contributor
"Breast cancer is a devastating malady with a profound emotional impact. As such, improvements in QoL from image guided breast PET/CT or PET/MRI were not observed in this cohort of women with cancer. For women with breast cancer PET/CT or PET/MRI may provide benefit only when the target lesion is identified as a potential site of disease (n = 5)." - Anonymous Online Contributor
"Although this is the first study to evaluate the efficacy of a PET-CT in breast cancer, we have shown a significant clinical and imaging response. Clinical and imaging response may be a good tool to guide the management of breast cancer patients and may lead to clinical trials. The use of PET-CT might be a cost-effective method to assess the tumour burden. It might be also investigated as a means to monitor the metastatic spread and to diagnose metastatic disease in advanced stage breast cancer before starting treatment. Further prospective studies are required to clarify whether this PET-CT can determine the best treatment option for breast cancer and which imaging modality can reflect the most favourable oncologic outcome." - Anonymous Online Contributor